Drug · DIN 02280949
RAN-RISPERIDONE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 13, 2012; first marketed June 30, 2006.
- Drug Identification Number (DIN)
- 02280949
- Company (DIN owner)
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 3 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 13, 2006: NOC 8021New Drug Submission (NDS) · New manufacturer and product name
Other DINs named RAN-RISPERIDONE
- DIN 02280906 · Cancelled Post Market
- DIN 02280914 · Cancelled Post Market
- DIN 02280922 · Cancelled Post Market
- DIN 02280930 · Cancelled Post Market
- DIN 02280957 · Cancelled Post Market